Illumina Inc (ILMN)

398.85 -0.76  -0.19% NASDAQ Mar 5, 20:00 USD
View Full Chart
Price Chart
View All ILMN News

News

View All Events

Events

Date Type Description
04/30/2021 Earnings Illumina Inc First Quarter Earnings Results for 2021
04/30/2021 Misc Illumina Inc First Quarter Earnings Conference Call for 2021
02/17/2021 Misc Illumina Inc Annual Report for 2020
02/11/2021 Earnings Illumina Inc Fourth Quarter Earnings Result for 2020
02/11/2021 17:00 EST Misc Illumina Inc Fourth Quarter Earnings Conference Call for 2020
10/29/2020 Earnings Illumina Inc Third Quarter Earnings Result for 2020
10/29/2020 14:00 PDT Misc Illumina Inc Third Quarter Earnings Conference Call for 2020
08/06/2020 17:00 EDT Misc Illumina Inc Second Quarter Earnings Conference Call for 2020
08/06/2020 Earnings Illumina Inc Second Quarter Earnings Result for 2020
05/27/2020 10:00 PDT Misc Illumina Inc Annual General Meeting for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.illumina.com
  • Investor Relations URL: http://www.illumina.com/company/investor-information.html
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Apr. 30, 2021
  • Last Earnings Release: Feb. 11, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

Top Fund Holders

Symbol Name Weighting
IBB iShares Nasdaq Biotechnology ETF 4.92%
EGFFX Edgewood Growth Retail 4.55%
HQH Tekla Healthcare Investors 4.48%
ZCG.TO BMO Concentrated Global Equity ETF 4.21%
FBT First Trust NYSE Arca Biotech ETF 3.84%
LGRCX Loomis Sayles Growth C 2.64%
VWIGX Vanguard International Growth Inv 2.30%
MSHLX Morgan Stanley Inst Growth L 1.64%
XLV Health Care Select Sector SPDR® ETF 1.37%
FGSRX Franklin Growth R 1.26%
VHT Vanguard Health Care ETF 1.15%
VWUSX Vanguard US Growth Investor 1.05%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.